Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jinhai International Group Holdings Limited ( (HK:2225) ) has shared an update.
Jinhai Medical Technology Limited has entered into a five-year cooperation framework agreement with Ningbo Verykind Medical Device Co., Ltd., a subsidiary of David Medical Group, to collaborate on endoscope products for international markets. This partnership aims to enhance product delivery efficiency, cost competitiveness, and global academic influence through resource optimization and international certifications. The agreement is expected to broaden Jinhai’s income stream and align with its development strategy, ultimately benefiting shareholders.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the manufacturing of minimally invasive surgery medical products. The company is engaged in international cooperation to expand its market reach and enhance its product offerings.
Average Trading Volume: 3,820,832
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$7.34B
For an in-depth examination of 2225 stock, go to TipRanks’ Overview page.